The future of Cell & Gene Therapies at ISCT 2022

ISCT 2022

ValitaCell’s Head of Cell Therapy, Dr. Stephanie Davies and Senior Scientist, Dr. Marilina Piemontese attended the International Society for Cell & Gene Therapy (ISCT) in San Francisco from the 4th to 7th of May. The expressed aim of the ISCT is to “translate cell & gene therapies into safe and effective treatments to improve patients’ lives”. Now in it’s 30th year, the best minds in the industry gathered together to hear the latest developments and listen to other experts in the field. ValitaCell’s Cell Therapy programme continues to gather pace and Dr. Marilina presented a poster entitled: “DESI-MSI as novel analytical tool for metabolic profiling of Mesenchymal Stem Cells in different media formulations”. The team looks forward to sharing further feedback on our Cell Therapy journey over the next number of months.

Want to talk about our products?

Hi, I’m Eligio, Business Development Manager at ValitaCell. Fill in the form to the right and I’ll get in touch with you soon!

    I agree to receive marketing communication from ValitaCell by e-mail

    The controller of your personal data is ValitaCell. We process your personal data in order to respond to your questions and for sending marketing communication, if you agreed. You have the right to access data, the right to request rectification, deletion or limitation of their processing, data transfer, the right to object, as well as the right to lodge a complaint to the supervisory body. Full information about processing of personal data can be found in the Privacy Policy.

    Show More